Literature DB >> 23509983

Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution.

Morteza Mahmoudi1, Fiona Quinlan-Pluck, Marco P Monopoli, Sara Sheibani, Hojatollah Vali, Kenneth A Dawson, Iseult Lynch.   

Abstract

Superparamagnetic iron oxide nanoparticles (SPIONs) are recognized as promising nanodiagnostic materials due to their biocompatibility, unique magnetic properties, and their application as multimodal contrast agents. As coated SPIONs have potential use in the diagnosis and treatment of various brain diseases such as Alzheimer's, a comprehensive understanding of their interactions with Aβ and other amyloidogenic proteins is essential prior to their clinical application. Here we demonstrate the effect of thickness and surface charge of the coating layer of SPIONs on the kinetics of fibrillation of Aβ in aqueous solution. A size and surface area dependent "dual" effect on Aβ fibrillation was observed. While lower concentrations of SPIONs inhibited fibrillation, higher concentrations increased the rate of Aβ fibrillation. With respect to coating charge, it is evident that the positively charged SPIONs are capable of promoting fibrillation at significantly lower particle concentrations compared with negatively charged or uncharged SPIONs. This suggests that in addition to the presence of particles, which affect the concentration of monomeric protein in solution (and thereby the nucleation time), there are also effects of binding on the protein conformation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23509983      PMCID: PMC3605812          DOI: 10.1021/cn300196n

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  65 in total

1.  Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.

Authors:  Dominic M Walsh; Igor Klyubin; Julia V Fadeeva; William K Cullen; Roger Anwyl; Michael S Wolfe; Michael J Rowan; Dennis J Selkoe
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

2.  Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism.

Authors:  L Nielsen; R Khurana; A Coats; S Frokjaer; J Brange; S Vyas; V N Uversky; A L Fink
Journal:  Biochemistry       Date:  2001-05-22       Impact factor: 3.162

Review 3.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

4.  Probing the role of backbone hydrogen bonding in beta-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions.

Authors:  David J Gordon; Stephen C Meredith
Journal:  Biochemistry       Date:  2003-01-21       Impact factor: 3.162

5.  Requirements for generating sigmoidal time-course aggregation in nucleation-dependent polymerization model.

Authors:  Masato Kodaka
Journal:  Biophys Chem       Date:  2004-02-15       Impact factor: 2.352

6.  Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.

Authors:  D J Gordon; K L Sciarretta; S C Meredith
Journal:  Biochemistry       Date:  2001-07-27       Impact factor: 3.162

7.  Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF.

Authors:  T L Lowe; A Strzelec; L L Kiessling; R M Murphy
Journal:  Biochemistry       Date:  2001-07-03       Impact factor: 3.162

8.  Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Abeta1-40 fibrillogenesis.

Authors:  D J Gordon; R Tappe; S C Meredith
Journal:  J Pept Res       Date:  2002-07

9.  Fullerene inhibits beta-amyloid peptide aggregation.

Authors:  Jeong Eun Kim; Minyung Lee
Journal:  Biochem Biophys Res Commun       Date:  2003-04-04       Impact factor: 3.575

10.  Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation.

Authors:  Ruitian Liu; Chad McAllister; Yuri Lyubchenko; Michael R Sierks
Journal:  J Neurosci Res       Date:  2004-01-15       Impact factor: 4.164

View more
  25 in total

Review 1.  Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease.

Authors:  Thuy Trang Nguyen; Tuong Kha Vo; Giau Van Vo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.

Authors:  Houshang Amiri; Kolsoum Saeidi; Parvin Borhani; Arash Manafirad; Mahdi Ghavami; Valerio Zerbi
Journal:  ACS Chem Neurosci       Date:  2013-09-26       Impact factor: 4.418

3.  Deciphering the Biochemical Pathway and Pharmacokinetic Study of Amyloid βeta-42 with Superparamagnetic Iron Oxide Nanoparticles (SPIONs) Using Systems Biology Approach.

Authors:  Aman Chandra Kaushik; Ajay Kumar; Vivek Dhar Dwivedi; Shiv Bharadwaj; Sanjay Kumar; Kritika Bharti; Pavan Kumar; Ravi Kumar Chaudhary; Sarad Kumar Mishra
Journal:  Mol Neurobiol       Date:  2017-05-06       Impact factor: 5.590

Review 4.  Biomedical Applications of Zeolitic Nanoparticles, with an Emphasis on Medical Interventions.

Authors:  Hossein Derakhshankhah; Samira Jafari; Sajad Sarvari; Ebrahim Barzegari; Faezeh Moakedi; Milad Ghorbani; Behrang Shiri Varnamkhasti; Mehdi Jaymand; Zhila Izadi; Lobat Tayebi
Journal:  Int J Nanomedicine       Date:  2020-01-21

5.  Hybrid Graphene Oxide Based Plasmonic-Magnetic Multifunctional Nanoplatform for Selective Separation and Label-Free Identification of Alzheimer's Disease Biomarkers.

Authors:  Teresa Demeritte; Bhanu Priya Viraka Nellore; Rajashekhar Kanchanapally; Sudarson Sekhar Sinha; Avijit Pramanik; Suhash Reddy Chavva; Paresh Chandra Ray
Journal:  ACS Appl Mater Interfaces       Date:  2015-06-09       Impact factor: 9.229

6.  Dual-Functional Antioxidant and Antiamyloid Cerium Oxide Nanoparticles Fabricated by Controlled Synthesis in Water-Alcohol Solutions.

Authors:  Katarina Siposova; Veronika Huntosova; Ivana Garcarova; Yuliia Shlapa; Illia Timashkov; Anatolii Belous; Andrey Musatov
Journal:  Biomedicines       Date:  2022-04-19

7.  Gold nanocolloid-protein interactions and their impact on β-sheet amyloid fibril formation.

Authors:  Heloise R Barros; Maria Kokkinopoulou; Izabel C Riegel-Vidotti; Katharina Landfester; Héloïse Thérien-Aubin
Journal:  RSC Adv       Date:  2018-01-03       Impact factor: 4.036

8.  Few-layer bismuth selenides exfoliated by hemin inhibit amyloid-β1-42 fibril formation.

Authors:  Jian Peng; Yunjing Xiong; Zhiqin Lin; Liping Sun; Jian Weng
Journal:  Sci Rep       Date:  2015-05-28       Impact factor: 4.379

9.  Antibody-conjugated, dual-modal, near-infrared fluorescent iron oxide nanoparticles for antiamyloidgenic activity and specific detection of amyloid-β fibrils.

Authors:  Hadas Skaat; Enav Corem-Slakmon; Igor Grinberg; David Last; David Goez; Yael Mardor; Shlomo Margel
Journal:  Int J Nanomedicine       Date:  2013-10-29

Review 10.  Nanostructures: a platform for brain repair and augmentation.

Authors:  Ruxandra Vidu; Masoud Rahman; Morteza Mahmoudi; Marius Enachescu; Teodor D Poteca; Ioan Opris
Journal:  Front Syst Neurosci       Date:  2014-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.